Nanomaterials (Feb 2022)

Pharmacological Dose-Effect Profiles of Various Concentrations of Humanised Primary Bile Acid in Encapsulated Cells

  • Armin Mooranian,
  • Melissa Jones,
  • Daniel Walker,
  • Corina Mihaela Ionescu,
  • Susbin Raj Wagle,
  • Bozica Kovacevic,
  • Jacqueline Chester,
  • Thomas Foster,
  • Edan Johnston,
  • Jafri Kuthubutheen,
  • Daniel Brown,
  • Marcus D. Atlas,
  • Momir Mikov,
  • Hani Al-Salami

DOI
https://doi.org/10.3390/nano12040647
Journal volume & issue
Vol. 12, no. 4
p. 647

Abstract

Read online

Bile acids (BA)s are known surfactants and well-documented to play a major role in food digestion and absorption. Recently, potential endocrinological and formulation-stabilisation effects of BAs have been explored and their pharmacological effects on supporting cell survival and functions have gained wide interest. Hence, this study aimed to explore the hyper-glycaemic dependent dose-effect of the BA chenodeoxycholic acid (CDCA) when encapsulated with pancreatic β-cells, allowing assessment of CDCA’s impacts when encapsulated. Four different concentrations of the BA were prepared, and viable cells were encapsulated and incubated for 2 days. Multiple analyses were carried out including confocal imaging, glucose-induced cellular mitochondrial viability indices, insulin production, inflammatory biomarker analyses and cellular bioenergetics measurements. There was a significant dose-effect with different concentrations of the BA, affecting cellular viability and antioxidant activities, cell functions and insulin release, inflammatory biomarkers, and cellular-bioenergetics at different oxidative stress levels. The results demonstrate that, when encapsulated, the BA CDCA exerts positive pharmacological effects at the cellular level, and such effects are concentration dependent.

Keywords